Alteminostat
CAS No. 1246374-97-9
Alteminostat ( Alteminostat )
Catalog No. M10998 CAS No. 1246374-97-9
Alteminostat is a novel histone deacetylase (HDAC) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 336 | Get Quote |
|
50MG | 1782 | Get Quote |
|
100MG | 2250 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAlteminostat
-
NoteResearch use only, not for human use.
-
Brief DescriptionAlteminostat is a novel histone deacetylase (HDAC) inhibitor.
-
DescriptionAlteminostat is a novel histone deacetylase (HDAC) inhibitor.
-
SynonymsAlteminostat
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1246374-97-9
-
Formula Weight492.62
-
Molecular FormulaC27H36N6O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(N1CCN(C)CC1)N(CCCCCCC(NO)=O)C2=CC=C(C3=CC4=C(C=C3)C=NN4C)C=C2
-
Chemical NameN-[7-(hydroxyamino)-7-oxoheptyl]-4-methyl-N-[4-(1-methyl1H-indazol-6-yl)phenyl]piperazine-1 carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. PCT Int. Appl. (2010), WO 2010110545 A2 20100930.
molnova catalog
related products
-
RTS-V5
RTS-V5 (Dual HDAC-proteasome inhibitor RTS-V5) is the first-in-class, dual HDAC-proteasome inhibitor.
-
GSK-3117391
GSK-3117391 (CHR-5154) is a novel macrophage-targeted HDAC inhibitor.
-
Alteminostat
Alteminostat is a novel histone deacetylase (HDAC) inhibitor.